Immediate Impact

1 by Nobel laureates 6 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
2023 Standout
10 intermediate papers

Works of Hitoshi Arioka being referenced

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
2017
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Hitoshi Arioka 497 583 160 203 59 1.1k
Ronald E. Savage 338 631 279 331 43 1.3k
Man‐Hsin Hung 479 529 148 94 45 1.3k
Shengzhang Lin 476 463 39 132 35 1.3k
Zaina T. Al-Salama 252 312 125 117 35 956
Tomohide Tamura 518 714 85 77 44 1.2k
Kelly M. Quesnelle 388 564 158 126 32 1.1k
Zhiping Ruan 386 702 96 77 57 1.2k
Annamaria Piscazzi 309 788 87 86 39 1.2k
Miyuki Akutsu 512 620 150 57 40 1.2k
Chikashi Nakanishi 222 439 83 150 49 970

All Works

Loading papers...

Rankless by CCL
2026